Tetra Bio Pharma Inc TBPMQ

QIXLEEF™ is an effective analgesic for pain management

[Savage97]

The FDA provided it's guidance on the Company's nonclinical safety program required for marketing approval, which guides the Company to design a cost-effective strategy as part of the drug development program.  QIXLEEF™ is an inhaled cannabinoid-based product that reduces the use of opioids in patients with severe or chronic pain.   $$$

[Golddetector]

Tetra is trying to get marketing based on phase II reborn. Not sure if that is possible. If that happens that will be huge. I always thought it needs to complete phase III. At this stage QIXLEEF should be 500M price tag with positive results. Current market capital of 30M is far of the real value here. That is why you see many bashers hanging around on multiple boards. Look at Friday volumes for

[DONOOW]

Why are you making endless non sense scenarios to convince yourself that there is still hope on this company, last year the share price was 0.50$ and you were saying it's a bargain price, now it's 0.07 and still saying the same thing, I feel sorry for your illness

[Savage97]

I noticed the huge uptick in volume and think shorts will be covering as well.   Will be interesting to see how TBP trades this week as a buyout candidate!!!!!!!!!!!TBP!!!!!!!!!!!!!$$$!!!!!!!!!!!!!!!!!!!

[DONOOW]

Like every week. 0.05 - 0.08 until a significant drop .

[DONOOW]

Here the pumpers taking the guidance as a pre approval, Tell me why the day of the announcement you were +18% and the day after -18% to return to the parking lot , There is a big shareholder selling his shares ... Quietly...